有機藥用輔料市場－全球產業規模、佔有率、趨勢、機會及預測（按類型、功能、應用、地區和競爭格局分類，2021-2031年）

全球有機藥用輔料市場預計將從 2025 年的 105.6 億美元成長到 2031 年的 168.6 億美元，複合年成長率達到 8.11%。

有機藥用輔料是指源自經認證的天然來源的非活性成分，例如植物來源澱粉、樹膠和纖維素，它們在保持無化學成分特性的同時，被用於藥物製劑中。推動這一市場發展的主要因素是消費行為的根本性轉變，即更加重視預防性醫療保健以及對產品透明度的強烈需求，促使製造商用天然成分取代合成化學物質。近期行業數據也印證了這個趨勢。根據有機貿易協會 (OTA) 的報告，到 2024 年，美國有機非食品產品的銷售額將達到 62 億美元，這表明消費者對有機個人護理和醫療保健解決方案有著巨大的經濟投入，而這直接影響著藥品採購決策。

然而，維持穩定的有機供應鏈高成本且面臨許多複雜挑戰，阻礙了市場成長。世界各地對有機認證的嚴格要求導致原料頻繁短缺和價格波動。這種符合標準的藥用級原料短缺，使得生產商無法擴大生產規模，最終延緩了新型有機藥物製劑的商業性化上市。

市場促進因素

蓬勃發展的膳食補充劑和保健品產業是推動有機藥用輔料使用的主要動力。隨著人們對預防保健的日益關注，消費者顯然更傾向於選擇使用經認證的有機替代品（例如植物來源纖維素）製成的「潔淨標示」產品，而不是合成填充劑和粘合劑。這種轉變迫使製造商尋找與活性成分天然特性相符的原料，以維持產品標準並符合認證要求。近期的數據凸顯了消費者對這種需求的強度。根據責任營養委員會 (CRN) 於 2024 年 10 月發布的《2024 年膳食補充劑消費者調查》，75% 的美國人使用膳食補充劑，凸顯了有機輸送系統的巨大市場潛力。

同時，慢性病發病率的上升推動了整體藥品消費量的成長，從而對生物相容性輔料產生了持續的需求。對於糖尿病和腫瘤等高負擔疾病，使用能夠確保患者安全並最大限度降低長期毒性的輔料製定長期治療方案至關重要。根據美國癌症協會於2024年1月發布的《2024年癌症事實與數據》，美國新增癌症病例數預計將首次超過200萬例，凸顯了擴大藥品生產的迫切需求。目前，藥品生產主要依賴專利到期藥物，而有機澱粉因其功能穩定性和成本效益，其使用量正在增加。正如可及藥品協會在2024年指出的那樣，學名藥占美國所有處方箋的90%，這使其成為有機輔料應用的主要量主導途徑。

市場挑戰

高昂的營運成本和維護穩定有機供應鏈的複雜性，對全球有機藥用輔料市場的成長構成了重大障礙。與傳統原料不同，有機膠和澱粉必須遵守嚴格的監管標準，而這些標準在國際上差異很大。認證系統的碎片化造成了物流延誤，並限制了符合標準的藥用級原料的供應。因此，製造商難以實現高效生產所需的規模經濟，導致價格不穩定，並阻礙了製藥公司轉型為有機配方。

天然成分需求的不斷成長與全球用於有機農業的耕地面積有限之間存在的巨大差距，進一步加劇了這一結構性挑戰。國際有機農業運動聯盟（IFOAM-Organics International）報告稱，到2024年，全球僅2.0%的耕地用於有機耕作。認證種植面積的匱乏直接限制了所需植物來源成分的供應，迫使生產者依賴高成本且不穩定的採購管道，最終延緩了新型有機藥物的商業性化上市。

市場趨勢

隨著製造商尋求克服有機成分相對於合成成分的天然性能局限性，用於增強功能的共加工有機添加劑的興起正在改變市場模式。為了克服基礎有機澱粉中諸如壓縮性和流動性差等技術難題，供應商正在加速開發共加工系統，將多種有機成分整合到單一的高性能顆粒中。這種向功能性、高附加價值有機解決方案的轉變正在推動顯著的商業性擴張。根據羅蓋特公司於2025年3月發布的“2024會計年度全年業績報告”，該公司製藥解決方案部門的銷售額達到8.18億歐元，比上年成長20%，主要得益於功能性製劑形式和植物來源膠囊技術的戰略成長。

同時，客製化有機輔料以提高複雜活性藥物成分（API）的溶解度已成為關鍵趨勢，這是現代藥物研發管線分子複雜性日益增加的必然結果。隨著藥物研發轉向溶解度更低、親油性的分子，人們越來越依賴脂質載體和有機增溶劑（例如環糊精）來確保足夠的生物有效性。這項技術需求在近期的製劑統計數據中也得到了印證。美國化學學會於2025年2月發布的一項研究《透過添加液態水溶助劑提高活性藥物成分的溶解度》顯示，約90%處於臨床試驗和研究階段的新型活性藥物成分水溶性較差，這凸顯了開發能夠穩定這些複雜製劑的先進有機輔料的迫切需求。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球有機藥用輔料市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 依類型（油脂化學品、碳水化合物、石油化學品、蛋白質、其他）
  • 依功能分類（粘合劑、包衣劑、著色劑、崩壞、其他功能）
  • 依用途（口服製劑、外用製劑、注射劑、其他用途）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

6. 北美有機藥用輔料市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國家分析
  • 美國
  • 加拿大
  • 墨西哥

7. 歐洲有機藥用輔料市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國家分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

8. 亞太地區有機藥用輔料市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

9. 中東和非洲有機藥用輔料市場展望

• 市場規模及預測
• 市佔率及預測
• 中東和非洲：國家分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

10. 南美洲有機藥用輔料市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國家分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進要素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 最新進展

第13章 全球有機藥用輔料市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的可能性
• 供應商電力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Roquette Freres SA
• DuPont de Nemours Inc.
• Ashland Inc.
• BASF SE
• Kerry Group plc
• Evonik Industries AG
• Croda International plc
• The Lubrizol Corporation
• Innophos Holdings Inc.
• Wacker Chemie AG

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Organic Pharmaceutical Excipients Market is anticipated to expand from USD 10.56 Billion in 2025 to USD 16.86 Billion by 2031, achieving a CAGR of 8.11%. Organic pharmaceutical excipients are inactive ingredients obtained from certified natural origins, including plant-based starches, gums, and celluloses, which are used to create medication formulations while upholding a chemical-free profile. The primary force driving this market is a fundamental change in consumer behavior favoring preventative healthcare and a strong demand for product transparency, which urges manufacturers to substitute synthetic chemicals with natural options. This driver is supported by recent industry data; the Organic Trade Association reported that in 2024, sales of organic non-food products in the United States reached $6.2 billion, indicating a significant economic dedication to organic personal care and health solutions that directly impacts pharmaceutical sourcing decisions.

Nevertheless, market growth is hindered by the high costs and complexities involved in maintaining consistent organic supply chains. The rigorous regulations required to obtain and keep organic certification across various global regions frequently result in raw material shortages and fluctuating prices. This scarcity of compliant pharmaceutical-grade ingredients prevents manufacturers from effectively scaling production, thereby retarding the commercial introduction of new organic drug formulations.

Market Driver

The booming nutraceutical and dietary supplement industry acts as a major driver for the use of organic pharmaceutical excipients. With consumers placing greater emphasis on preventative health, there is a marked preference for clean-label products that utilize certified organic alternatives, such as plant-based celluloses, over synthetic fillers and binders. This shift compels manufacturers to match their ingredient sourcing with the natural characteristics of active components to uphold product standards and meet certification requirements. The scale of this consumer demand is highlighted by recent data; the Council for Responsible Nutrition's '2024 Consumer Survey on Dietary Supplements', released in October 2024, found that 75% of Americans use dietary supplements, emphasizing the vast market potential for organic delivery systems.

In parallel, the rising incidence of chronic diseases is boosting overall drug consumption, generating consistent demand for biocompatible excipients. Conditions with a high burden, such as diabetes and oncology, necessitate long-term treatment plans using excipients that ensure patient safety and minimize toxicity over time. According to the 'Cancer Facts & Figures 2024' published by the American Cancer Society in January 2024, new cancer cases in the U.S. were projected to surpass 2 million for the first time, indicating a critical need for expanded pharmaceutical manufacturing. This production is largely sustained by off-patent drugs, which increasingly employ organic starches for their functional stability and cost-effectiveness; the Association for Accessible Medicines noted in 2024 that generic medicines comprised 90% of all prescriptions dispensed in the U.S., representing a key volume-driven pathway for organic excipient adoption.

Market Challenge

The high operational costs and complexity associated with sustaining consistent organic supply chains represent a significant obstacle to the Global Organic Pharmaceutical Excipients Market's growth. In contrast to conventional ingredients, organic gums and starches must strictly comply with regulatory standards that differ considerably across international borders. This fragmentation in certification causes logistical delays and limits the availability of compliant pharmaceutical-grade raw materials. Consequently, manufacturers find it difficult to reach the economies of scale needed for efficient production, resulting in price instability that deters pharmaceutical companies from shifting to organic formulations.

This structural difficulty is worsened by a severe gap between the rising demand for natural ingredients and the limited global land allocated to organic farming. IFOAM - Organics International reported in 2024 that only 2.0 percent of global agricultural land was managed organically. This shortage of certified cultivation space directly restricts the supply of necessary plant-based inputs, compelling manufacturers to depend on costly and unstable sourcing networks, which ultimately delays the commercial release of new organic drug products.

Market Trends

The rise of Co-Processed Organic Excipients for Enhanced Functionality is transforming the market as manufacturers look to surmount the natural performance limitations of organic ingredients relative to synthetics. To mitigate technical issues like inadequate compressibility and flowability in basic organic starches, suppliers are increasingly developing co-processed systems that merge multiple organic components into a single high-performance particle. This move toward functional, value-added organic solutions is fueling substantial commercial expansion; Roquette's '2024 Full Year Results' from March 2025 showed that their Pharma Solutions division achieved sales of €818 million, a 20% rise from the prior year, largely supported by strategic growth in functional delivery forms and plant-based capsule technologies.

At the same time, the Customization of Organic Excipients for Solubility Enhancement in Complex APIs has become a vital trend, necessitated by the molecular intricacy of contemporary drug pipelines. As pharmaceutical research and development shifts toward more poorly soluble and lipophilic molecules, there is an increased dependence on organic solubilizers, such as lipid-based carriers and cyclodextrins, to guarantee sufficient bioavailability. This technical requirement is highlighted by recent formulation statistics; a February 2025 study titled 'Solubility Enhancement of Active Pharmaceutical Ingredients through Liquid Hydrotrope Addition' by the American Chemical Society revealed that roughly 90% of emerging active pharmaceutical ingredients in clinical trials and research demonstrate poor water solubility, creating an urgent need for advanced organic excipients capable of stabilizing these complex formulations.

Key Market Players

• Roquette Freres SA
• DuPont de Nemours Inc.
• Ashland Inc.
• BASF SE
• Kerry Group plc
• Evonik Industries AG
• Croda International plc
• The Lubrizol Corporation
• Innophos Holdings Inc.
• Wacker Chemie AG

Report Scope

In this report, the Global Organic Pharmaceutical Excipients Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Organic Pharmaceutical Excipients Market, By Type

• Oleochemicals
• Carbohydrates
• Petrochemicals
• Protein
• Other

Organic Pharmaceutical Excipients Market, By Function

• Binders
• Coating Agents
• Colorants
• Disintegrates
• Other Functions

Organic Pharmaceutical Excipients Market, By Application

• Oral Formulations
• Topical Formulations
• Parenteral Formulations
• Other Applications

Organic Pharmaceutical Excipients Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Organic Pharmaceutical Excipients Market.

Available Customizations:

Global Organic Pharmaceutical Excipients Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Organic Pharmaceutical Excipients Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Oleochemicals, Carbohydrates, Petrochemicals, Protein, Other)
  • 5.2.2. By Function (Binders, Coating Agents, Colorants, Disintegrates, Other Functions)
  • 5.2.3. By Application (Oral Formulations, Topical Formulations, Parenteral Formulations, Other Applications)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Organic Pharmaceutical Excipients Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Function
  • 6.2.3. By Application
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Organic Pharmaceutical Excipients Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Function
      • 6.3.1.2.3. By Application
  • 6.3.2. Canada Organic Pharmaceutical Excipients Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Function
      • 6.3.2.2.3. By Application
  • 6.3.3. Mexico Organic Pharmaceutical Excipients Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Function
      • 6.3.3.2.3. By Application

7. Europe Organic Pharmaceutical Excipients Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Function
  • 7.2.3. By Application
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Organic Pharmaceutical Excipients Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Function
      • 7.3.1.2.3. By Application
  • 7.3.2. France Organic Pharmaceutical Excipients Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Function
      • 7.3.2.2.3. By Application
  • 7.3.3. United Kingdom Organic Pharmaceutical Excipients Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Function
      • 7.3.3.2.3. By Application
  • 7.3.4. Italy Organic Pharmaceutical Excipients Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Function
      • 7.3.4.2.3. By Application
  • 7.3.5. Spain Organic Pharmaceutical Excipients Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Function
      • 7.3.5.2.3. By Application

8. Asia Pacific Organic Pharmaceutical Excipients Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Function
  • 8.2.3. By Application
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Organic Pharmaceutical Excipients Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Function
      • 8.3.1.2.3. By Application
  • 8.3.2. India Organic Pharmaceutical Excipients Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Function
      • 8.3.2.2.3. By Application
  • 8.3.3. Japan Organic Pharmaceutical Excipients Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Function
      • 8.3.3.2.3. By Application
  • 8.3.4. South Korea Organic Pharmaceutical Excipients Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Function
      • 8.3.4.2.3. By Application
  • 8.3.5. Australia Organic Pharmaceutical Excipients Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Function
      • 8.3.5.2.3. By Application

9. Middle East & Africa Organic Pharmaceutical Excipients Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Function
  • 9.2.3. By Application
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Organic Pharmaceutical Excipients Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Function
      • 9.3.1.2.3. By Application
  • 9.3.2. UAE Organic Pharmaceutical Excipients Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Function
      • 9.3.2.2.3. By Application
  • 9.3.3. South Africa Organic Pharmaceutical Excipients Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Function
      • 9.3.3.2.3. By Application

10. South America Organic Pharmaceutical Excipients Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Function
  • 10.2.3. By Application
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Organic Pharmaceutical Excipients Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Function
      • 10.3.1.2.3. By Application
  • 10.3.2. Colombia Organic Pharmaceutical Excipients Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Function
      • 10.3.2.2.3. By Application
  • 10.3.3. Argentina Organic Pharmaceutical Excipients Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Function
      • 10.3.3.2.3. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Organic Pharmaceutical Excipients Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Roquette Freres SA
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. DuPont de Nemours Inc.
• 15.3. Ashland Inc.
• 15.4. BASF SE
• 15.5. Kerry Group plc
• 15.6. Evonik Industries AG
• 15.7. Croda International plc
• 15.8. The Lubrizol Corporation
• 15.9. Innophos Holdings Inc.
• 15.10. Wacker Chemie AG

16. Strategic Recommendations

17. About Us & Disclaimer